Artemis Therapeutics Competitors and Similar CompaniesClear all

Artemis Therapeutics's competitors and similar companies include UCB, Mankind Pharma and Genentech.

	Artemis Therapeutics Artemis Therapeutics (formerly known as New York Global Innovations) is a biopharmaceutical company that engages in the development of agents for the prevention and treatment of severe and potentially life-threatening infectious diseases.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 1997	Founding Date 1928	Founding Date 1995	Founding Date 1976
Type	Type Private	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations New York, US HQ San Diego, US	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations New Delhi, IN HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 1	Employees 9,052	Employees 16,2532% increase	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) $311k (FY, 2022)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $54k (FY, 2022)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $257k (FY, 2022)	Gross profit €7.2b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($1.4m) (FY, 2022)	Net income €1.6b (FY, 2025)	Net income N/A	Net income N/A